Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function

Hiroyuki Tsutsui, Miyuki Tsuchihashi, Akira Takeshita

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

Patients with congestive heart failure (CHF) and preserved systolic function are very common. Despite the high prevalence of this syndrome, very little information is known regarding its mortality and morbidity (e.g., readmission), or the efficacy of drugs. The purpose of this study was to compare the clinical characteristics and prognosis among consecutively hospitalized patients with CHF and preserved versus depressed left ventricular systolic function. Patients with severe aortic or mitral valve disease were excluded from the study. Patients were categorized based on the values of ejection fraction (EF) as having "preserved" (EF >50%), "intermediate" (EF 40% to 50%), or "depressed" (EF <40%) systolic function. Clinical characteristics as well as mortality and hospital readmission rates during 2.4 years of follow-up were recorded for each patient. Sixty-one patients (35%) had preserved systolic function, 73 (43%) had depressed function, and 38 (22%) had intermediate function. Patients with preserved systolic function were more often women and had a higher prevalence of left ventricular hypertrophy (all p <0.05). At follow-up, cumulative survival probabilities were similar between patients with preserved systolic function and those with systolic dysfunction (p = 0.84). Readmission rates were also comparable between preserved and depressed systolic function (36% vs 48%; p = NS). The prognosis of CHF patients with preserved systolic function was similar to those with systolic dysfunction. In light of these findings, effective therapeutic strategy for this subset of patients is needed.

Original languageEnglish
Pages (from-to)530-533
Number of pages4
JournalAmerican Journal of Cardiology
Volume88
Issue number5
DOIs
Publication statusPublished - Sep 1 2001

Fingerprint

Patient Readmission
Heart Failure
Mortality
Left Ventricular Hypertrophy
Aortic Valve
Mitral Valve
Left Ventricular Function
Morbidity

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. / Tsutsui, Hiroyuki; Tsuchihashi, Miyuki; Takeshita, Akira.

In: American Journal of Cardiology, Vol. 88, No. 5, 01.09.2001, p. 530-533.

Research output: Contribution to journalArticle

@article{3ea97e39df184a7bb75458a6cc704b79,
title = "Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function",
abstract = "Patients with congestive heart failure (CHF) and preserved systolic function are very common. Despite the high prevalence of this syndrome, very little information is known regarding its mortality and morbidity (e.g., readmission), or the efficacy of drugs. The purpose of this study was to compare the clinical characteristics and prognosis among consecutively hospitalized patients with CHF and preserved versus depressed left ventricular systolic function. Patients with severe aortic or mitral valve disease were excluded from the study. Patients were categorized based on the values of ejection fraction (EF) as having {"}preserved{"} (EF >50{\%}), {"}intermediate{"} (EF 40{\%} to 50{\%}), or {"}depressed{"} (EF <40{\%}) systolic function. Clinical characteristics as well as mortality and hospital readmission rates during 2.4 years of follow-up were recorded for each patient. Sixty-one patients (35{\%}) had preserved systolic function, 73 (43{\%}) had depressed function, and 38 (22{\%}) had intermediate function. Patients with preserved systolic function were more often women and had a higher prevalence of left ventricular hypertrophy (all p <0.05). At follow-up, cumulative survival probabilities were similar between patients with preserved systolic function and those with systolic dysfunction (p = 0.84). Readmission rates were also comparable between preserved and depressed systolic function (36{\%} vs 48{\%}; p = NS). The prognosis of CHF patients with preserved systolic function was similar to those with systolic dysfunction. In light of these findings, effective therapeutic strategy for this subset of patients is needed.",
author = "Hiroyuki Tsutsui and Miyuki Tsuchihashi and Akira Takeshita",
year = "2001",
month = "9",
day = "1",
doi = "10.1016/S0002-9149(01)01732-5",
language = "English",
volume = "88",
pages = "530--533",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function

AU - Tsutsui, Hiroyuki

AU - Tsuchihashi, Miyuki

AU - Takeshita, Akira

PY - 2001/9/1

Y1 - 2001/9/1

N2 - Patients with congestive heart failure (CHF) and preserved systolic function are very common. Despite the high prevalence of this syndrome, very little information is known regarding its mortality and morbidity (e.g., readmission), or the efficacy of drugs. The purpose of this study was to compare the clinical characteristics and prognosis among consecutively hospitalized patients with CHF and preserved versus depressed left ventricular systolic function. Patients with severe aortic or mitral valve disease were excluded from the study. Patients were categorized based on the values of ejection fraction (EF) as having "preserved" (EF >50%), "intermediate" (EF 40% to 50%), or "depressed" (EF <40%) systolic function. Clinical characteristics as well as mortality and hospital readmission rates during 2.4 years of follow-up were recorded for each patient. Sixty-one patients (35%) had preserved systolic function, 73 (43%) had depressed function, and 38 (22%) had intermediate function. Patients with preserved systolic function were more often women and had a higher prevalence of left ventricular hypertrophy (all p <0.05). At follow-up, cumulative survival probabilities were similar between patients with preserved systolic function and those with systolic dysfunction (p = 0.84). Readmission rates were also comparable between preserved and depressed systolic function (36% vs 48%; p = NS). The prognosis of CHF patients with preserved systolic function was similar to those with systolic dysfunction. In light of these findings, effective therapeutic strategy for this subset of patients is needed.

AB - Patients with congestive heart failure (CHF) and preserved systolic function are very common. Despite the high prevalence of this syndrome, very little information is known regarding its mortality and morbidity (e.g., readmission), or the efficacy of drugs. The purpose of this study was to compare the clinical characteristics and prognosis among consecutively hospitalized patients with CHF and preserved versus depressed left ventricular systolic function. Patients with severe aortic or mitral valve disease were excluded from the study. Patients were categorized based on the values of ejection fraction (EF) as having "preserved" (EF >50%), "intermediate" (EF 40% to 50%), or "depressed" (EF <40%) systolic function. Clinical characteristics as well as mortality and hospital readmission rates during 2.4 years of follow-up were recorded for each patient. Sixty-one patients (35%) had preserved systolic function, 73 (43%) had depressed function, and 38 (22%) had intermediate function. Patients with preserved systolic function were more often women and had a higher prevalence of left ventricular hypertrophy (all p <0.05). At follow-up, cumulative survival probabilities were similar between patients with preserved systolic function and those with systolic dysfunction (p = 0.84). Readmission rates were also comparable between preserved and depressed systolic function (36% vs 48%; p = NS). The prognosis of CHF patients with preserved systolic function was similar to those with systolic dysfunction. In light of these findings, effective therapeutic strategy for this subset of patients is needed.

UR - http://www.scopus.com/inward/record.url?scp=0035451308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035451308&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(01)01732-5

DO - 10.1016/S0002-9149(01)01732-5

M3 - Article

C2 - 11524063

AN - SCOPUS:0035451308

VL - 88

SP - 530

EP - 533

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 5

ER -